FDA clears Alpha Tau to advance REGAIN trial enrolment
The decision follows the FDA’s review of an interim safety report for the first three patients treated in the trial.
Analysis
View MoreTracking carbon, tracing change
To track and verify embodied emissions through every stage of the supply chain, leading OEMs are piloting blockchain-anchored digital product passports (DPPs). Ellie Philpotts talks to Chris Taylor, sustainability lead...
Go with the flow
Harnessing automation
How smart can it be?
Killer nanopatterns